87 results
DEFA14A
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
4 Jun 19
Additional proxy soliciting materials
5:07pm
Pharmaceuticals Incorporated (the “Company”).
The Company’s board of directors has adopted a policy of inclusiveness related to age, gender, race, ethnicity … committee considers diversity of age, gender, race, ethnicity, international experience and other specialized experience in each candidate search
8-K
EX-10
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
5 Dec 05
Entry into a Material Definitive Agreement
12:00am
of any gender include each other gender; (ii)
words using the singular or plural number also include the plural or singular
number, respectively; (iii
8-K
EX-10.2
znn g3635
24 Aug 09
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
lsmmvj6wb dd1ra
9 Aug 18
Entry into a Material Definitive Agreement
9:05am
8-K
EX-10.3
ejgw7u5ofznv7axo7bm7
24 Aug 09
Entry into a Material Definitive Agreement
12:00am
425
EX-10.2
z2x0vb9
24 Aug 09
Business combination disclosure
12:00am
8-K
EX-10.2
2r0b j2rgojv7e8
24 Dec 09
Ligand Completes Neurogen Acquisition
12:00am
425
EX-10.1
qjve9agwzr ck
26 Sep 08
Business combination disclosure
12:00am
8-K
EX-10.4
xr5uy
24 Dec 09
Ligand Completes Neurogen Acquisition
12:00am
8-K
EX-10.5
tusb7b px2
24 Aug 09
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
9apdpyn8uo06hjht
24 Dec 09
Ligand Completes Neurogen Acquisition
12:00am
425
EX-10.4
kvniesw0ky
24 Aug 09
Business combination disclosure
12:00am
425
EX-10.5
vd24zn cv1
24 Aug 09
Business combination disclosure
12:00am